Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era

Emerging evidence indicates that thromboembolic complications are a key determinant of inhospital mortality of patients with COVID-19. Prophylactic anticoagulation therapy is an important component of inhospital management of patients with COVID-19. Considering that millions of patients worldwide ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Heng, Cai, Xin, Zhou, Qing, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer India Pvt. Ltd. 2020
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951679/
https://www.ncbi.nlm.nih.gov/pubmed/35372741
http://dx.doi.org/10.4103/2470-7511.305417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951679/
https://www.ncbi.nlm.nih.gov/pubmed/35372741
http://dx.doi.org/10.4103/2470-7511.305417

Ejemplares similares